Projects funded by the NCN
First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effective therapy of neurodegenerative diseases with cognitive impairment
2023/51/B/NZ7/02177
Keywords:
necroptosis 5-HT6 receptor triazine hydantoin neurodegenerative diseases Alzheimer's disease molecular modeling neuroprotection behavioral tests pharmacokinetics
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_15:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 13
Call: OPUS 26 - announced on 2023-09-18
Amount awarded: 3 088 400 PLN
Project start date (Y-m-d): 2024-07-10
Project end date (Y-m-d): 2028-07-09
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.